WHO标准对88例骨髓增生异常综合征重新分型价值的探讨
出处
《滨州医学院学报》
2003年第6期458-459,共2页
Journal of Binzhou Medical University
参考文献3
-
1郝玉书,徐世荣.骨髓增生异常综合征与白血病前期[J].中华血液学杂志,2000,21(4):173-173. 被引量:17
-
2赵维莅,吴文,徐岚,闫骅,唐炜,胡炯,陈钰,李军民,曾晓颖,陈赛娟,沈志祥,王振义.骨髓增生异常综合征患者预后分析及各预后评估系统的比较[J].中华血液学杂志,2002,23(11):599-600. 被引量:2
-
3陈协群,孙秉中,郭文怡,朱华锋.尿激酶联合低分子肝素钙治疗阵发性睡眠性血红蛋白尿症合并突发性耳聋一例[J].中华血液学杂志,2000,21(10):545-545. 被引量:4
二级参考文献10
-
1Bennett JM,Catovsky D,Daniel MT,et al.Pro p osals for the classification of the my elod y s p lastic s y ndromes[].British Journal of Haematology.1982
-
2Greenberg P,Cox C,le Beau MM.International scoring system for evaluating prognosis in myelodysplastic syndromes[].Blood.1997
-
3Bennett JM.W orld Health Organization classification of the acute leukem ias and myelodysplastic syndrome[].International Journal of Hematology.2000
-
4Mitelman F,ed.ISCN(1995): An International System for Human Cytogenotic Nomenclature[]..1995
-
5Pfeilstocker M,Reisner R,Nosslinger T,et al.Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics[].British Journal of Haematology.1999
-
6Willman CL.Molecular genetic features of myelodysplastic syndromes(MDS)[].Leukemia.1998
-
7Pedersen-Bjergaard J,Pedersen M,Roulston D,et al.Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia[].Blood.1995
-
8Oguma S,Yoshida Y,Uchino H,et al.Clinical characteristics of Japanese patients with primary myelodysplastic syndromes, a co-operative study based on 838 cases.Anemia Study Group of the Ministry of Health and Welfare[].Leukemia Research.1995
-
9Wimazal F,Sperr WR,Kundi M,et al.Prognostic value of lactate dehydrogenase activity in myelodysplastic syndromes[].Leukemia Research.2001
-
10Germing U,Gattermann N,Strupp C,et al.Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1 600 patients[].Leukemia Research.2000
共引文献20
-
1刘汉芳.低增生性非原始细胞增多44例骨髓涂片及病理学分析[J].中国煤炭工业医学杂志,2005,8(2):133-134.
-
2罗文纪,钟湘云,李仪,超奇.24例骨髓增生异常综合征染色体分析[J].浙江临床医学,2005,7(9):901-902. 被引量:2
-
3陆进,查庆桂.具有骨髓增生性疾病特征的慢性粒-单核细胞白血病1例(附文献复习)[J].黑龙江医学,2005,29(11):879-880.
-
4赵舒文,程远.AML与继发于MDS白血病的骨髓象比较[J].实用医技杂志,2006,13(4):550-550. 被引量:1
-
5韩秀华,李秀梅,朱贵华,庄万传.CAG方案治疗MDS-RAEB的近期疗效观察[J].白血病.淋巴瘤,2006,15(3):217-218. 被引量:3
-
6冯敏,周学慧,杨琳,孙娟.八种化疗药物对MUTZ-1和KG1a细胞系增生抑制作用的研究[J].白血病.淋巴瘤,2006,15(6):416-418.
-
7黄川英.铁粒幼细胞性贫血(SA)与难治性贫血(MDS-RARS)的临床及细胞形态学特点分析[J].中国实用医药,2008,3(16):68-69.
-
8李云龙,张曦,陈幸华,高蕾,文钦,曾蕴璟,刘嘉,罗晓庆.CEAG方案治疗低增生性MDS-RAEB和AML的临床观察[J].西部医学,2010,22(7):1219-1220. 被引量:3
-
9武海松.小剂量EVA方案治疗骨髓增生异常综合征临床观察[J].中原医刊,2000,27(11):38-39.
-
10耿良权,吴竞生,汪健.14例骨髓增生异常综合征的染色体研究[J].安徽医药,2001,5(4):280-281.
-
1傅世华,黄海萍.胰高糖素—胰岛素释放试验对糖尿病分型价值[J].湖南医科大学学报,1992,17(4):387-389.
-
2高春记,宋增璇.髓系造血生长因子与临床应用[J].国外医学(输血及血液学分册),1991,14(2):89-91. 被引量:3
-
3刘绍模.利用WHO方案和FAB分型标准对63例MDS患者分型的评价[J].四川省卫生管理干部学院学报,2003,22(3):175-176.
-
4王雅飞.改变糖尿病 我们共同来参与[J].糖尿病之友,2007(12):92-92.
-
5沈艳萍.老年急性心肌梗死60例的护理[J].中国误诊学杂志,2009,9(8):1940-1941.
-
6郝玉书,徐世荣.骨髓增生异常综合征与白血病前期[J].中华血液学杂志,2000,21(4):173-173. 被引量:17
-
7MarshJ CW,Geary CG,薛永权.再生障碍性贫血是一种白血病前期性疾病吗?[J].国外医学(输血及血液学分册),1993,16(1):17-19.
-
8骨髓增生异常综合征不仅仅是“白血病前期”[J].中华医学信息导报,2002,17(16):13-13.
-
9张德春,王爽,王韶.以皮肤病变为首发症状的骨髓增生异常综合征[J].中国麻风皮肤病杂志,2008,24(6):474-475. 被引量:1
-
10苑德才.关于流行性出血热统一命名及译名的规定[J].口岸卫生控制,2000,5(1):43-43.